Capital First is proving to be an ideal investment so far owing to its smooth and secular upward trajectory. Daljeet Kohli, Sharekhan & HDFC Sec have confidently asserted that there are more gains in store for us from the stock
Prof. Sanjay Bakshi’s brilliant stock pick has given 300%+ gains in just 16 months. However, the premise on which the Prof. made the recommendation, namely, strong brand, market dominance and “moat” still holds good and it is not too late to buy the stock say experts
When ace stock pickers of the pedigree of Dolly Khanna, Vijay Kedia, Nalanda Capital & Jwalamukhi collectively show confidence in a stock, we should dive in first and ask questions later. If we had done that, we would be basking in great riches today. Luckily, it is not too late to make amends
Saurabh Mukherjea has followed his conservative formula of focusing only on well-run high-quality companies with clean accounts and sensible capital allocation. His “Good and Clean Portfolio” for 2014 has heavily outperformed the Benchmark Index. Will the 2015 Portfolio do the same?
Keeping an eye on what super-savvy investors like Ramesh Damani & Kenneth Andrade are doing pays rich dividends. Today, their mutual stock pick surged 20% on the back of blockbuster Q3FY15 results, spreading riches all around
Rakesh Jhunjhunwala holds a formidable stake in the Pharma & Healthcare sector in the form of Lupin & Aurobindo Pharma. His latest stock pick is a mid-cap with top-quality management, strong brand image and ambitious growth plans
Amar Ambani of IIFL has issued reports on Express Stock Ideas + Call Success and Updates + Q3FY15 Result Updates with clear-cut buy/hold/sell recommendations and target prices of 24 stocks
When a stock is called a “classic turnaround story” it is expected to demonstrate dramatic and volatile movements. Today, the stock plunged 20% on the back of pathetic Q3FY15 results. However, Daljeet Kohli has not given up hope and still foresees nearly 100% gains from the stock
Recent Comments